Skip to main content



) --




) hit a new 52-week high Friday as it is currently trading at $35.89, above its previous 52-week high of $35.88 with 24,883 shares traded as of 9:35 a.m. ET. Average volume has been 196,400 shares over the past 30 days.

Cyberonics has a market cap of $901.5 million and is part of the

health care

sector and

health services

industry. Shares are up 2.4% year to date as of the close of trading on Thursday.

Scroll to Continue

TheStreet Recommends

Cyberonics, Inc., a neuromodulation company, engages in the design, development, sale, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression. The company has a P/E ratio of 31.9, above the average health services industry P/E ratio of 30.5 and above the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Cyberonics as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. You can view the full

Cyberonics Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center